Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Psl is an exopolysaccharide produced by the bacterium *Pseudomonas aeruginosa*. It is crucial for biofilm formation, structural integrity, and resistance to environmental stresses. Psl contributes to antimicrobial resistance, immune evasion, and host interaction. Its biosynthesis is regulated by intracellular levels of cyclic-di-GMP. Targeting Psl is a potential strategy for combating *P. aeruginosa* infections.
Inhibition of Psl synthesis; disruption of Psl structure; targeting biofilm formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa Exopolysaccharide Psl (Psl).